價(jià)格 | ¥158 | ¥333 | ¥538 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 BMH-21 | 英文名稱:BMH-21 |
CAS:896705-16-1 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.53% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T1767 |
名稱 | BMH-21 |
描述 | BMH-21, a small molecule DNA intercalator, binds ribosomal DNA and inhibits RNA polymerase I (Pol I) transcription and not affects phosphorylation of H2AX. |
細(xì)胞實(shí)驗(yàn) | The cells are maintained at 37 °C in a humidified atmosphere containing 5% CO2. U2OS osteosarcoma cells are cultured in DMEM supplemented with 15% fetal bovine serum. Cells are plated in 96-well plates at a density of 10000 cells/well in triplicate and incubated for 48 h with the compounds. Viability is determined using WST-1 cell proliferation reagent. (Only for Reference) |
激酶實(shí)驗(yàn) | [14C]-monosaccharide uptake inhibition experiments: Stable cell lines over-expressing hSGLT-1, -2, -4, -5 or -6 or rSGLT-1 or -2 are used for the sodium-dependent monosaccharide transport inhibition assay. Cells are pre-incubated in 200 μL uptake buffer (10 mM HEPES, 137 mM NaCl, 5.4 mM KCl, 2.8 mM CaCl2, 1.2 mM MgCl2, 50 μg/ml Gentamycin, 0.1% BSA) for 25 minutes at 37°C. 10 μM Cytochalasin B and test compound is added at different concentrations 15 minutes before the initiation of the uptake experiment. The uptake reaction is started by the addition of 0.6 μCi [14C]-labelled monosaccharide i.e. [14C]-labelled AMG, glucose, fructose, mannose or myo-inositol, in 0.1 mM AMG (or the respective non-radioactive monosaccharide). After incubation for 60 minutes (hSGLT-5), 90 minutes (hSGLT-4) or 4 hours (hSGLT-2) at 37°C, the cells are washed three times with 300 μL PBS and then lysed in 0.1 N NaOH with intermittent shaking for 5 minutes. The lysate is mixed with 200 μL MicroScint 40 and shaken for 15 minutes and counted for radioactivity in the TopCount NXT. For SGLT-4 and SGLT-5 assays cells are pre-incubated in pre-treatment buffer (uptake buffer containing choline chloride instead of NaCl) for 25 minutes prior to addition of uptake buffer. |
體外活性 | 在小鼠異種移植物中,BMH-21可抑制腫瘤生長(zhǎng). |
體內(nèi)活性 | 在U2OS癌癥細(xì)胞系中,BMH-21可使NCL易位(IC50:0.07 μM)和RPA194降解(IC50:0.05 μM)。BMH-21引起RPA194依賴性的蛋白酶體破壞,RPA194為Pol I全復(fù)合物的大催化亞基蛋白。通過(guò)引起核仁應(yīng)激,BMH-21也可有效抑制細(xì)胞活性。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | Ethanol : 2 mg/mL (5.54 mM), Heating is recommended. DMSO : <1 mg/mL (insoluble or slightly soluble), Heating is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) |
關(guān)鍵字 | nucleolus | polymerase | damage | intercalation | transcription | RNA | BMH 21 | response | DNA | BMH-21 | inhibit | Inhibitor | DNA/RNA Synthesis |
相關(guān)產(chǎn)品 | N-Nitrosodiethylamine | Acyclovir | Guanidine hydrochloride | Trimethoprim | Procaine | Pemetrexed | Folic acid | Resveratrol | 5-Fluorouracil | Temozolomide | Thymidine | Ribavirin |
相關(guān)庫(kù) | 抑制劑庫(kù) | 血腦屏障通透化合物庫(kù) | 抗癌活性化合物庫(kù) | 經(jīng)典已知活性庫(kù) | 抗癌化合物庫(kù) | 已知活性化合物庫(kù) | 細(xì)胞周期化合物庫(kù) | 抗衰老化合物庫(kù) | 表型篩選靶點(diǎn)鑒定庫(kù) | 毒性化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-15 | |
¥207.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
¥1291.84 |
VIP11年
|
西格瑪奧德里奇(上海)貿(mào)易有限公司
|
2023-10-27 | |
詢價(jià) |
VIP10年
|
南京艾爾莎生物科技有限公司
|
2023-04-10 | |
¥680 |
上海偉寰生物科技有限公司
|
2020-01-17 | ||
¥770 |
武漢科昊佳生物科技有限公司
|
2020-01-15 | ||
詢價(jià) |
鴻拓生物技術(shù)股份有限公司
|
2020-01-13 |